IRX Therapeutics
Latest round
- Series B
Last raised
- Jan 2009
Total raised
- Undisclosed
Investors
- 2
About IRX Therapeutics
Founded in 1994 and is based in New York, US, IRX Therapeutics, Inc. operates as a biotechnology company that engages in the discovery and development of immune therapies for the treatment of cancer and viral diseases.
Who invested in IRX Therapeutics
2 investors across 1 round
See all investors in IRX Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 14, 2009
Amount
Undisclosed
Investors
Questions about IRX Therapeutics
Who invested in IRX Therapeutics?
IRX Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IRX Therapeutics raised?
IRX Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did IRX Therapeutics last raise money?
IRX Therapeutics's most recent round on record is a Series B, in Jan 2009.
What does IRX Therapeutics do?
Founded in 1994 and is based in New York, US, IRX Therapeutics, Inc.
Where is IRX Therapeutics headquartered?
IRX Therapeutics is headquartered in New York, US.
Which VCs invest in companies like IRX Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at IRX Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like IRX Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.